Abstract

Abstract Complications of dengue fever are understudied in oncology. In patients undergoing chemotherapy, the immunosuppressive effects of drugs increase susceptibility to infections, such as dengue, complicating diagnosis and treatment. Here, we report two cases highlighting the challenges and importance of early detection in managing dengue fever alongside chemotherapy-induced immunosuppression. Both patients presented with severe leucopenia and thrombocytopenia, common to both chemotherapy side effects and dengue, complicating clinical management. Early recognition of dengue has allowed for appropriate management, resulting in full recovery.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.